BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease. Front Cell Infect Microbiol 2021;11:615075. [PMID: 33968794 DOI: 10.3389/fcimb.2021.615075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mysiris DS, Vavougios GD, Karamichali E, Papoutsopoulou S, Stavrou VT, Papayianni E, Boutlas S, Mavridis T, Foka P, Zarogiannis SG, Gourgoulianis K, Xiromerisiou G. Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis. IJMS 2022;23:9739. [DOI: 10.3390/ijms23179739] [Reference Citation Analysis]
2 Oliveira MET, Paulino GVB, Dos Santos Júnior ED, da Silva Oliveira FA, Melo VMM, Ursulino JS, de Aquino TM, Shetty AK, Landell MF, Gitaí DLG. Multi-omic Analysis of the Gut Microbiome in Rats with Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy. Mol Neurobiol 2022. [PMID: 35962889 DOI: 10.1007/s12035-022-02984-3] [Reference Citation Analysis]
3 Dinan K, Dinan TG. Gut Microbes and Neuropathology: Is There a Causal Nexus? Pathogens 2022;11:796. [DOI: 10.3390/pathogens11070796] [Reference Citation Analysis]
4 Medvedev A, Buneeva O. Tryptophan Metabolites as Mediators of Microbiota-Gut-Brain Communication: Focus on Isatin. Front Behav Neurosci 2022;16:922274. [DOI: 10.3389/fnbeh.2022.922274] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Arena G, Sharma K, Agyeah G, Krüger R, Grünewald A, Fitzgerald JC. Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop. Curr Neurol Neurosci Rep 2022. [PMID: 35674870 DOI: 10.1007/s11910-022-01207-5] [Reference Citation Analysis]
6 Beckers M, Bloem BR, Verbeek MM. Mechanisms of peripheral levodopa resistance in Parkinson's disease. NPJ Parkinsons Dis 2022;8:56. [PMID: 35546556 DOI: 10.1038/s41531-022-00321-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fu S, Shih L, Wu P, Hsieh Y, Lee C, Lin S, Wang H. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data. Front Cell Infect Microbiol 2022;12:871710. [DOI: 10.3389/fcimb.2022.871710] [Reference Citation Analysis]
8 Voigt RM, Wang Z, Brown JM, Engen PA, Naqib A, Goetz CG, Hall DA, Metman LV, Shaikh M, Forsyth CB, Keshavarzian A. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105780] [Reference Citation Analysis]
9 Liu X, Du ZR, Wang X, Sun XR, Zhao Q, Zhao F, Wong WT, Wong KH, Dong X. Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson’s disease. Food Research International 2022;155:111067. [DOI: 10.1016/j.foodres.2022.111067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wang L, Zhao Z, Zhao L, Zhao Y, Yang G, Wang C, Gao L, Niu C, Li S. Lactobacillus plantarum DP189 Reduces α-SYN Aggravation in MPTP-Induced Parkinson’s Disease Mice via Regulating Oxidative Damage, Inflammation, and Gut Microbiota Disorder. J Agric Food Chem . [DOI: 10.1021/acs.jafc.1c07711] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
11 Linard M, Ravier A, Mougué L, Grgurina I, Boutillier AL, Foubert-Samier A, Blanc F, Helmer C. Infectious Agents as Potential Drivers of α-Synucleinopathies. Mov Disord 2022. [PMID: 35040520 DOI: 10.1002/mds.28925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kramer P. Mitochondria-Microbiota Interaction in Neurodegeneration. Front Aging Neurosci 2021;13:776936. [PMID: 35002678 DOI: 10.3389/fnagi.2021.776936] [Reference Citation Analysis]
13 Ramachandra VH, Sivanesan S, Koppal A, Anandakumar S, Howell MD, Sukumar E, Vijayaraghavan R. Embelin and levodopa combination therapy for improved Parkinson's disease treatment. Transl Neurosci 2022;13:145-62. [PMID: 35855085 DOI: 10.1515/tnsci-2022-0224] [Reference Citation Analysis]
14 Kouki MA, Pritchard AB, Alder JE, Crean S. Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease? J Alzheimers Dis 2021. [PMID: 34897087 DOI: 10.3233/JAD-215103] [Reference Citation Analysis]
15 Jena R, Jain R, Muralidharan S, Yanamala VL, Zubair Z, Kantamaneni K, Jalla K, Renzu M, Alfonso M. Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Parkinson's Disease. Cureus 2021;13:e19035. [PMID: 34853754 DOI: 10.7759/cureus.19035] [Reference Citation Analysis]
16 Laudes M, Geisler C, Rohmann N, Bouwman J, Pischon T, Schlicht K. Microbiota in Health and Disease-Potential Clinical Applications. Nutrients 2021;13:3866. [PMID: 34836121 DOI: 10.3390/nu13113866] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Mishima Y, Ishihara S. Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome. Int J Mol Sci 2021;22:10235. [PMID: 34638577 DOI: 10.3390/ijms221910235] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
18 Tinkov AA, Martins AC, Avila DS, Gritsenko VA, Skalny AV, Santamaria A, Lee E, Bowman AB, Aschner M. Gut Microbiota as a Potential Player in Mn-Induced Neurotoxicity. Biomolecules 2021;11:1292. [PMID: 34572505 DOI: 10.3390/biom11091292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Franco R, Casanovas B, Camps J, Navarro G, Martínez-Pinilla E. Antixoxidant Supplements versus Health Benefits of Brief/Intermittent Exposure to Potentially Toxic Physical or Chemical Agents. Curr Issues Mol Biol 2021;43:650-64. [PMID: 34287292 DOI: 10.3390/cimb43020047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]